SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: technetium9/16/2024 1:27:08 PM
   of 195
 
RVNC down $1.00/15.18%. Crown missed tender offer deadline last Friday. They offered to take the company private for $6.66/sh, and it’s hovered around $6.58/sh ever since then, until today.

Quoting iHub RVNC board:

Re Fosun approval, the original 8-K announcing the Fosun deal said:

Under the Agreement, Revance will receive a non-refundable upfront payment of $30 million within thirty (30) business days of the date of the Agreement and is eligible to receive (i) additional contingent payments of up to $230.5 million upon the achievement of specified milestones based on (a) the submission and approval of Biologics License Applications (“BLAs”) for certain aesthetic and therapeutic indications and (b) first time calendar year net sales, and (ii) tiered royalty payments in low double digit to high teen percentages on annual net sales.

Quoting Bob Dylan:

And something is happening here
But you don't know what it is
Do you, Mister Jones?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News